The Galien Foundation
medal
Join us

    The Galien Foundation
      Prix Galien Medal
      Join us
      Prix Galien Coin
      Join us

      Prix Galien Korea 2026 Laureates

      dropdown-iconBest Pharmaceutical Product

      Oscotec Inc. for Lazertinib

      Yuhan Corporation for Leclaza® (Lazertinib mesylate)

      dropdown-iconBest Biotechnology Product

      Alteogen Inc. for TERGASE® 

      dropdown-iconBest Medical Technology

      BIONEER Corporation for ExiStation™ FA 96 / Fully-Automated Molecular Diagnostics Platform

      dropdown-iconBest Digital Health Solution

      Dot Inc. for Dot Pad X

      dropdown-iconBest Startup

      ADEL Inc.

      Ban_Ki_moon3

      “The Prix Galien is the right event, on the right issue at the right time. I thank the Galien Foundation for bringing us together and for recognizing that a healthier world is a safer world and a more just world.”
      - Ban Ki-moon, UN Secretary-General at the 2010 Prix Galien USA Awards Ceremony

      Galien Korea Forum

      The inaugural Galien Korea Forum brought together leading voices from research, industry, regulatory bodies, and government, creating a unique platform for exchange and collaboration around the future of global health. Held alongside the World Knowledge Forum on September 10, 2026, the Forum set the stage for the first edition of the Prix Galien Korea.

      Makary-1
      Dr. Marty Makary, Former Commissioner of the US Food and Drug Administration (FDA)
      Galien Forum Korea 2-1
      Dr. Leonard Schleifer (Co-Founder, Co-Chairman of the Board, President & CEO Regeneron) & Dr. Namho Kim, Director, Business Development & Partnerships, Flagship Pioneering
      Galien Forum Korea 1-1
      Reverend Andrea Roberto Ciucci, Chancellor, Pontifical Academy for Life, Vatican City
      Galien Forum Korea 3-1
      Dr. Thomas Lines, Founder, Chairman & CEO, Quercis Pharma & Dr. Sung Joo Lee, Founder & CEO, Orum Therapeutics & Dr. Hail Kim, Professor, KAIST
      Prix Galien Korea Awards

      The first edition of the Prix Galien Korea honored the most exciting innovations in the life sciences, recognizing the teams behind life-changing drugs, biologics, technologies, methodologies, and digital solutions. As an honor of the highest order for research, development, and the distribution of innovations improving the human condition, the Prix Galien celebrated Korea’s contribution to the global health community.

      Yuhan-1
      Yuhan Corporation co-receiving the Prix Galien Korea 2026 award for Best Pharmaceutical Product, Leclaza® (Lazertinib mesylate).
      Oscotec-1
      Oscotec Inc. co-honored with the Prix Galien Korea 2026 Best Pharmaceutical Product award for Lazertinib.
      Altogen-1
      Alteogen Inc. accepting the Prix Galien Korea 2026 award for Best Biotechnology Product, TERGASE®.
      Bioneer-1
      BIONEER Corporation celebrated as the Prix Galien Korea 2026 Best Medical Technology laureate for the ExiStation™ FA 96 platform.
      Dot-1
      Dot Inc. recognized with the Prix Galien Korea 2026 Best Digital Health Solution award for Dot Pad X.
      Adel-1
      ADEL Inc. named the Prix Galien Korea 2026 Best Startup laureate.  

      Prix Galien Korea Awards Committee

      A prestigious committee comprising eight of the finest distinguished researchers in their fields will be chaired by Professor Park Yeong Min, MD. The committee will judge submissions to the inaugural prize in the categories Best Biotechnology Product, Best Digital Health Solution, Best Medical Technology, Best Pharmaceutical Product, and Best Startup.


      The inaugural edition of the Prix Galien Korea is co-hosted in collaboration with: